AR030862A1 - Formulaciones medicinales en aerosol - Google Patents

Formulaciones medicinales en aerosol

Info

Publication number
AR030862A1
AR030862A1 ARP010104722A ARP010104722A AR030862A1 AR 030862 A1 AR030862 A1 AR 030862A1 AR P010104722 A ARP010104722 A AR P010104722A AR P010104722 A ARP010104722 A AR P010104722A AR 030862 A1 AR030862 A1 AR 030862A1
Authority
AR
Argentina
Prior art keywords
aerosol
bulking
medical formulations
less
propiliodone
Prior art date
Application number
ARP010104722A
Other languages
English (en)
Inventor
Philip Anthony Jinks
Mark H Mackenzie
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0024711.4A external-priority patent/GB0024711D0/en
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of AR030862A1 publication Critical patent/AR030862A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

El empleo de agentes de abultamiento o agrupacion en partículas que tengan un diámetro de masa medio extremadamente pequeno menor de 1 micron, preferiblemente menor de 300nm, en formulaciones farmacéuticas en aerosol que comprenden una suspension de partículas de droga en un propelente. Ejemplos de agente de abultamiento o agrupacion incluyen el ácido ascorbico, sacáridos, polisacáridos, amino ácidos, sales orgánicas e inorgánicas urea y propiliodona.
ARP010104722A 2000-10-09 2001-10-09 Formulaciones medicinales en aerosol AR030862A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024711.4A GB0024711D0 (en) 2000-10-09 2000-10-09 Medicinal aerosol formulations
GBGB0122512.7A GB0122512D0 (en) 2000-10-09 2001-09-18 Medical aerosol formations

Publications (1)

Publication Number Publication Date
AR030862A1 true AR030862A1 (es) 2003-09-03

Family

ID=26245133

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104722A AR030862A1 (es) 2000-10-09 2001-10-09 Formulaciones medicinales en aerosol

Country Status (17)

Country Link
EP (1) EP1324749B1 (es)
JP (1) JP5021149B2 (es)
CN (1) CN1635870A (es)
AR (1) AR030862A1 (es)
AT (1) ATE320242T1 (es)
AU (2) AU2002211311B2 (es)
CA (1) CA2425035A1 (es)
CZ (1) CZ2003983A3 (es)
DE (1) DE60118021T2 (es)
ES (1) ES2260299T3 (es)
HU (1) HUP0302311A3 (es)
IL (1) IL155088A0 (es)
MX (1) MXPA03002991A (es)
NO (1) NO20031597L (es)
NZ (1) NZ525054A (es)
PL (1) PL199420B1 (es)
WO (1) WO2002030394A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1920763B2 (en) 2000-11-30 2022-06-15 Vectura Limited Pharmaceutical compositions for inhalation
ES2689704T3 (es) 2000-11-30 2018-11-15 Vectura Limited Partículas para usar en una composición farmacéutica
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ES2281691T3 (es) * 2002-08-23 2007-10-01 Schering Corporation Composiciones farmaceuticas.
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
EP1635845A1 (en) 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
WO2006040598A2 (en) * 2004-10-12 2006-04-20 Generics (Uk) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
RU2007133547A (ru) 2005-02-10 2009-03-20 Глаксо Груп Лимитед (GB) Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
CN100435784C (zh) * 2005-07-25 2008-11-26 管晓虹 含有和包封中药成分的无机盐纳米粒子的制备方法
CN100335038C (zh) * 2005-07-25 2007-09-05 江桥 含有生物活性物质和中药成分包封的无机盐纳米粒子的制备方法
DE102006040535A1 (de) * 2006-08-30 2008-03-13 Beiersdorf Ag Aerosolzubereitung umfassend Peloide
CN101380309B (zh) * 2007-09-03 2012-05-09 李浩莹 一种定量吸入气雾剂及其制备方法
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
JP2014519519A (ja) 2011-06-15 2014-08-14 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規３，４，４ａ，１０ｂ−テトラヒドロ−１Ｈ−チオピラノ［４，３−ｃ］イソキノリン化合物
BR112013031791A2 (pt) 2011-06-17 2017-01-31 Takeda Gmbh derivados de ftalazinona-pirrolopirimidinacarboxamida
WO2018069210A1 (en) 2016-10-10 2018-04-19 Takeda Gmbh Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN110755414A (zh) * 2019-11-12 2020-02-07 南京华盖制药有限公司 一种酒石酸阿福特罗气雾剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
JP4484247B2 (ja) * 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions

Also Published As

Publication number Publication date
NZ525054A (en) 2004-11-26
WO2002030394A2 (en) 2002-04-18
WO2002030394A3 (en) 2003-01-30
ES2260299T3 (es) 2006-11-01
EP1324749A2 (en) 2003-07-09
CN1635870A (zh) 2005-07-06
PL199420B1 (pl) 2008-09-30
HUP0302311A2 (hu) 2003-10-28
DE60118021D1 (de) 2006-05-11
MXPA03002991A (es) 2004-05-05
JP5021149B2 (ja) 2012-09-05
CA2425035A1 (en) 2002-04-18
AU2002211311B2 (en) 2006-08-31
ATE320242T1 (de) 2006-04-15
PL361135A1 (en) 2004-09-20
NO20031597D0 (no) 2003-04-08
HUP0302311A3 (en) 2006-07-28
IL155088A0 (en) 2003-10-31
DE60118021T2 (de) 2006-10-26
EP1324749B1 (en) 2006-03-15
CZ2003983A3 (cs) 2003-09-17
NO20031597L (no) 2003-05-30
AU1131102A (en) 2002-04-22
JP2004510808A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
AR030862A1 (es) Formulaciones medicinales en aerosol
MXPA05007158A (es) Formulacion farmaceutica con un agente activo insoluble.
BR0207005A (pt) Sistema de distribuição granular, processo para prepará-lo, uso do mesmo, produto ou composição flavorizado(a), e, produto ou composição perfumado(a)
AR018252A1 (es) Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral.
IT1296914B1 (it) Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
HUP0105089A2 (hu) A hatóanyagot-foszfolipiddel stabilizált diszpergálható mikrorészecskék forájában tartalmazó készítmények
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
DE60334924D1 (de) Anoteilchengrösse
ES2136883T3 (es) Nueva formulacion mejorada de aminoglucosido para administracion en forma de aerosol.
SE0002643D0 (sv) Microparticle inhalation formulations
DE69915733D1 (de) Kosmetische oder pharmazeutische Zusammensetzung in Form eines Feststoffs, welche verformt werden kann
ATE386506T1 (de) Verabreichung unlöslicher arzneistoffe
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
ES2167921T3 (es) Comprimido multiparticular perfeccionado de disgregacion rapida.
DK1435909T3 (da) Stabil sammensætning indeholdende partikler i en frossen vandig matrix
WO2005032511A3 (en) Nanoparticulate therapeutic biologically active agents
CO5611097A2 (es) Tableta farmaceutica
AR043272A1 (es) Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden
RS49764B (sr) Farmaceutski preparat za primenu na mukozu
DE60325887D1 (de) Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen
DE50310435D1 (de) Filmförmige, zerfallsfähige zubereitungen zur wirkstoff-freisetzung und verfahren zu deren herstellung
BR9913135A (pt) Formulação oral
JO2325B1 (en) A pharmaceutical composition with a flavoring taste and a process to prepare it
BRPI0014878B8 (pt) composição farmacêutica contendo ciclosonida para aplicação à mucosa
WO2001082868A3 (en) A medicinal aerosol formulation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal